135 related articles for article (PubMed ID: 21557705)
21. MicroRNAs as therapeutic targets and their potential applications in cancer therapy.
Cho WC
Expert Opin Ther Targets; 2012 Aug; 16(8):747-59. PubMed ID: 22690697
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA as a novel drug target for cancer therapy.
Liu X; Liu L; Xu Q; Wu P; Zuo X; Ji A
Expert Opin Biol Ther; 2012 May; 12(5):573-80. PubMed ID: 22428844
[TBL] [Abstract][Full Text] [Related]
23. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.
Kong D; Piao YS; Yamashita S; Oshima H; Oguma K; Fushida S; Fujimura T; Minamoto T; Seno H; Yamada Y; Satou K; Ushijima T; Ishikawa TO; Oshima M
Oncogene; 2012 Aug; 31(35):3949-60. PubMed ID: 22139078
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
[TBL] [Abstract][Full Text] [Related]
25. Current status of targeted therapies in advanced gastric cancer.
De Vita F; Giuliani F; Silvestris N; Rossetti S; Pizzolorusso A; Santabarbara G; Galizia G; Colucci G; Ciardiello F; Orditura M
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S29-34. PubMed ID: 22443228
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.
Kong WQ; Bai R; Liu T; Cai CL; Liu M; Li X; Tang H
FEBS J; 2012 Apr; 279(7):1252-60. PubMed ID: 22325466
[TBL] [Abstract][Full Text] [Related]
27. Macro-role of microRNA in gastric cancer.
Link A; Kupcinskas J; Wex T; Malfertheiner P
Dig Dis; 2012; 30(3):255-67. PubMed ID: 22722550
[TBL] [Abstract][Full Text] [Related]
28. miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
Sun T; Wang C; Xing J; Wu D
Eur J Cancer; 2011 Nov; 47(17):2552-9. PubMed ID: 21684154
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
30. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
Wu H; Huang M; Lu M; Zhu W; Shu Y; Cao P; Liu P
Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer.
Deng H; Guo Y; Song H; Xiao B; Sun W; Liu Z; Yu X; Xia T; Cui L; Guo J
Gene; 2013 Apr; 518(2):351-9. PubMed ID: 23333942
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-21 with therapeutic potential in autoimmune diseases.
Xu WD; Pan HF; Li JH; Ye DQ
Expert Opin Ther Targets; 2013 Jun; 17(6):659-65. PubMed ID: 23506112
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic significance of miR-10b expression in gastric carcinoma.
Wang YY; Ye ZY; Zhao ZS; Li L; Wang YX; Tao HQ; Wang HJ; He XJ
Hum Pathol; 2013 Jul; 44(7):1278-85. PubMed ID: 23351547
[TBL] [Abstract][Full Text] [Related]
34. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
Wu Q; Jin H; Yang Z; Luo G; Lu Y; Li K; Ren G; Su T; Pan Y; Feng B; Xue Z; Wang X; Fan D
Biochem Biophys Res Commun; 2010 Feb; 392(3):340-5. PubMed ID: 20067763
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
36. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression.
Sun Q; Gu H; Zeng Y; Xia Y; Wang Y; Jing Y; Yang L; Wang B
Cancer Sci; 2010 Oct; 101(10):2241-7. PubMed ID: 20666778
[TBL] [Abstract][Full Text] [Related]
37. microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.
Li CL; Nie H; Wang M; Su LP; Li JF; Yu YY; Yan M; Qu QL; Zhu ZG; Liu BY
Oncol Rep; 2012 Jun; 27(6):1960-6. PubMed ID: 22426647
[TBL] [Abstract][Full Text] [Related]
38. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer.
Guo X; Guo L; Ji J; Zhang J; Zhang J; Chen X; Cai Q; Li J; Gu Q; Liu B; Zhu Z; Yu Y
Biochem Biophys Res Commun; 2010 Jul; 398(1):1-6. PubMed ID: 20510161
[TBL] [Abstract][Full Text] [Related]
39. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.
Li N; Tang B; Zhu ED; Li BS; Zhuang Y; Yu S; Lu DS; Zou QM; Xiao B; Mao XH
FEBS Lett; 2012 Mar; 586(6):722-8. PubMed ID: 22321642
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of microRNA-143 and -145 in human gastric cancers.
Takagi T; Iio A; Nakagawa Y; Naoe T; Tanigawa N; Akao Y
Oncology; 2009; 77(1):12-21. PubMed ID: 19439999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
